drugset / Trial / NCT03994549
A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, single ascending dose trial in healthy subjects, randomized to ZP7570 or placebo within each cohort.
Timeline
- Start
- 2019-06-14
- Primary completion
- 2020-11-02
- Completion
- 2020-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ZP7570 | Unknown | — | Subcutaneous |
Indications
No indication recorded.